Coloplast Balance Sheet Health
Financial Health criteria checks 2/6
Coloplast has a total shareholder equity of DKK15.1B and total debt of DKK20.7B, which brings its debt-to-equity ratio to 137.2%. Its total assets and total liabilities are DKK48.6B and DKK33.5B respectively. Coloplast's EBIT is DKK6.9B making its interest coverage ratio 12.4. It has cash and short-term investments of DKK916.0M.
Key information
137.2%
Debt to equity ratio
kr.20.75b
Debt
Interest coverage ratio | 12.4x |
Cash | kr.916.00m |
Equity | kr.15.13b |
Total liabilities | kr.33.47b |
Total assets | kr.48.59b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CLPB.F's short term assets (DKK10.1B) do not cover its short term liabilities (DKK18.9B).
Long Term Liabilities: CLPB.F's short term assets (DKK10.1B) do not cover its long term liabilities (DKK14.5B).
Debt to Equity History and Analysis
Debt Level: CLPB.F's net debt to equity ratio (131.1%) is considered high.
Reducing Debt: CLPB.F's debt to equity ratio has increased from 58.5% to 137.2% over the past 5 years.
Debt Coverage: CLPB.F's debt is well covered by operating cash flow (26.6%).
Interest Coverage: CLPB.F's interest payments on its debt are well covered by EBIT (12.4x coverage).